Jun Ishihara
@BioengIshihara
Followers
286
Following
45
Media
8
Statuses
140
Lecturer at Imperial College London, principal investigator インペリアルカレッジロンドン講師 免疫創薬の研究室を運営しています。
London
Joined February 2020
Congratulations to Prof. David Baker on his Nobel Prize. @ImperialBioeng @imperialcollege hosted him for a seminar a few years ago!
0
1
3
PhD student Chuyi Wang won the best poster award at the European Congress of Immunology (ECI) 2024 in Dublin. Congratulations!
0
0
1
The Ishihara lab celebrated its three years of anniversary. It survived and thrived with great talents. Very lucky to work with good people.
1
0
25
Merry Christmas from the Ishihara lab. Our lab is still two years-old, but grew rapidly. We celebrated our achievements, diversity and team working culture.
1
0
7
Japanese research is no longer world class here’s why. A lot of young Japanese researchers went outside of Japan for better research environment.
nature.com
Nature - Despite a strong workforce, Japan’s research continues to slide down the indicators of quality.
0
1
3
I became a researcher because I wanted to solve unmet needs. I truly believe that with this funding, we can make a difference in brain tumors therapies.
We’ve awarded £1.5 million grant to find new ways to treat #glioblastoma at @imperialcollege. Led by Dr Jun Ishihara @BioengIshihara, researchers will harness the power of the immune system to help fight recurrent glioblastoma cells.
0
4
19
Congratulations, Martina. Great that you will be back to Chicago!.
Excited to share that I have accepted a position as Assistant Professor at @UChicago and that my lab will open its doors in October 2023 as part of @UChicagoImmuno. Contact me if you are interested in studying mechanisms of peripheral tolerance with us!.
0
0
0
I am thrilled to share this news. Our lab was funded by the Brain tumour charity, with 1.5 million GBP, 5 years. Our ambition is to create drug for the patients who desperately need therapeutic options. @BrainTumourCSO @imperialcollege @ImperialBioeng
thebraintumourcharity.org
Dr Jun Ishihara aims to use a novel immunotherapy and harness the power of the immune system to treat glioblastomas.
1
3
24
RT @DdelAlamo: "DiPPI: A curated dataset for drug-like molecules in protein-protein interfaces" . Server: https://t….
0
51
0
New Nature communications paper is out!.
So excited for our new publication in @NatureComms demonstrating a novel membrane-bound IL-12 engineered regionally-delivered CAR T cell approach to target multi-metastatic solid tumors. Congrats to @heejunlee920505, @JohnPMuradPhD and #pricemanlab #coh
0
0
1
RT @UWproteindesign: Thrilled to have hosted the Korean Minister of Health & Welfare at our institute last week. Minister Cho met with some….
0
18
0
We are hiring several #postdocs At Imperial College London @jishiharalab .
nature.com
Imperial College London (UK) Salary £45,593 – £49,305+benefits, Immunology, protein engineering, cancer, oncology, drug delivery system, antibody
0
0
2
Congratulations!.
Big news: I'll be starting as an Assistant Professor at @NorthwesternU in January joint between @NorthwesternBME and @nu_chbe as part of @NU_NURTURE!
1
0
1
RT @tim_cook: Welcome to the era of spatial computing with Apple Vision Pro. You’ve never seen anything like this before! .
0
30K
0
My lab at #imperialcollegelondon is looking for a lab technician (#technician).Also we are looking for #postdocs in #immunotherapy #oncology #immunoengineeing.
lnkd.in
This link will take you to a page that’s not on LinkedIn
0
0
0
My lab at Imperial college London is still hiring two postdocs! Share this post to someone who is interested in immuno-engineering and immuno-oncology.#postdoc #postdocposition #imperialcollegelondon.
0
1
4
I am so proud of Jeff. I have been working with him for 9 years. He is a great researcher, mentor and respectful person. Joining his lab was my best decision in my life.
@UChicagoPME professor Jeffrey Hubbell has been elected into the @theNASciences for his work in bioengineering and immunotherapy. 👏.Hubbell is the only current @UChicago faculty member to be elected to all three academies - Sciences, Engineering, and Medicine.
0
1
9
RT @NatureComms: CAR-T cells targeting STEAP1 for prostate cancer therapy. #CancerResearch @natrescancer @vipulbhat….
0
3
0
Very happy to share a Nature communications paper with @jklee_lab @SaulPriceman @vipulbhatia24 . This is the first original research paper from @ImperialBioeng , @jishiharalab .We are keen to develop new effective immunotherapy for cancers!.
nature.com
Nature Communications - Six transmembrane epithelial antigen of the prostate 1 (STEAP1) is a highly enriched cell surface antigen expressed in prostate cancer. Here the authors describe the design...
3
5
24